Founded in 2014, PRECIRIX® is a clinical-stage biotech company developing targeted radiopharmaceuticals with camelid single-domain antibody fragments. Its lead product, CAM-H2, is in Phase I/II trials for HER2-positive cancers. The theranostic platform combines imaging-based patient selection with therapy, enabling precise, safe, and personalized cancer treatment.
Precirix
Precirix develops precision radiopharmaceuticals, advancing biotechnology research to enable targeted diagnostics and therapies. The company focuses on innovative solutions that improve accuracy, efficacy, and outcomes in medical imaging and treatment.
About Precirix
Recently Added Startups
Better Stack
Better Stack creates beautifully designed, powerful observability tools that help developers build a better internet, enabling faster, more reliable software delivery while making the development process easier and more enjoyable.
WinWinner
WinWinner is a crowdlending platform based in Belgium that enables people to use government-backed loans to invest their funds in small businesses in their communities.
Related Post
Top HealthTech Startups in Belgium 2026
Belgium
Wobby.ai
Wobby helps business teams access data instantly by replacing unused dashboards with AI data analysts that deliver accurate, trusted insights on demand, reducing data team overload and decision-making delays.
AmphiStar
AmphiStar is the pioneer in the development, production, scaling up, and distribution of sophorolipid biosurfactants.
Biotech
ALGIECEL
ALGIECEL is a BioSolutions company producing sustainable, high-quality ingredients at scale, addressing global demand while protecting ecosystems, and transforming costly production systems into commercially viable, eco-friendly solutions for decarbonization.
AmphiStar
AmphiStar is the pioneer in the development, production, scaling up, and distribution of sophorolipid biosurfactants.
Brussels
Precirix
Precirix develops precision radiopharmaceuticals, advancing biotechnology research to enable targeted diagnostics and therapies. The company focuses on innovative solutions that improve accuracy, efficacy, and outcomes in medical imaging and treatment.
Confo Therapeutics
Confo Therapeutics leverages the dynamic structures of GPCRs to transform drug discovery, developing innovative therapies by targeting complex protein conformations for more precise and effective treatments.
Contact us: contact@startuprise.co.uk